Product description
100mg tablets (AUST R 128635). 200mg tablets (AUST R 104279). 400mg tablets (AUST R 104280).
See a list of details to help identify the product.
Reason the product is recalled
The Therapeutic Goods Administration has cancelled the registration of Lumiracoxib because of serious liver side effects associated with the use of the drug.
The hazards to consumers
Potentially life-threatening or could cause a serious risk to health (Class I).
What consumers should do
Patients taking Lumiracoxib should stop taking the medicine now and discuss alternative treatments with their doctor.
Details to help identify the product.
Supplier running the recall
Novartis Pharmaceuticals Australia Pty Ltd
Where the product was sold
Nationally
Responsible regulators
Regulators are established or appointed by government. They enforce regulations and rules.
Quote PRA number 2007/9450 when contacting a regulator about this recall.
Recall and remedy questions
Contact the Therapeutic Goods Administration if you have:
- a question about the remedy being offered to you by the business that is responsible for managing this recall, or
- concerns about the way the business is managing this recall.